vix.ing · top · new · best · stats

PET/CT and SPECT/CT for Infection in Joints and Bones: An Overview and Future Directions

2023/11/27 by Kgomotso M.G. Mokoala, Kgomotso Mokoala, Honest Ndlovu +4 · 1 citation
Medicine · #Infectious Diseases and Tuberculosis #Infective Endocarditis Diagnosis and Management #Orthopedic Infections and Treatments

paper · doi:10.1053/j.semnuclmed.2023.10.007

openalex publication_date 2023/11/27 · crossref created 2023/11/27 · crossref issued 2024/05/01 · crossref published 2024/05/01 · crossref published-print 2024/05/01 · crossref deposited 2024/05/15 · openalex created_date 2025/10/10 · crossref indexed 2026/07/30 · openalex updated_date 2026/07/31

Abstract

Infections of the bones and joints, if misdiagnosed, may result in serious morbidity and even mortality. A prompt diagnosis followed by appropriate management may reduce the socioeconomic impact of bone and joint infections. Morphologic imaging such as ultrasound and plain radiographs form the first line investigations, however, in early infections findings may be negative or nonspecific. Nuclear medicine imaging techniques play a complementary role to morphologic imaging in the diagnosis of bone and joint infections. The availability of hybrid systems (SPECT/CT, SPECT/MRI, PET/CT or PET/MRI) offers improved specificity with ability to assess the extent of infection. Bone scans are useful as a gatekeeper wherein negative scans rule out sepsis with a good accuracy, however positive scans are nondiagnostic and more specific tracers should be considered. These include the use of labeled white blood cells and antigranulocyte antibodies. Various qualitative and quantitative interpretation criteria have been suggested to improve the specificity of the scans. PET has better image resolution and 18F-FDG is the major tracer for PET imaging with applications in oncology and inflammatory/infective disorders. It has demonstrated improved sensitivity over the SPECT based tracers, however, still suffers from lack of specificity. 18F-FDG PET has been used to monitor therapy in bone and joint infections. Other less studied, noncommercialized SPECT and PET tracers such as 111In-Biotin, 99mTc-Ubiquicidin, 18F-Na-Fluoride, 18F-labeled white blood cells and 124I-Fialuridine to name a few have shown great promise, however, their role in various bone and joint infections has not been established. Hybrid imaging with PET or PET/MRI offers huge potential for improving diagnostics in infections of the joints and bones.

Citations

Cited by

Related